Cargando…
Sativex-induced neurobehavioral effects: causal or concausal? A practical advice!
Nabiximols (Sativex) is an oromucosal spray, containing delta-9 tetrahydrocannabinol (THC) and cannabidiol (CBD), used as treatment for unresponsive spasticity in multiple sclerosis (MS) patients. Sativex is thought to not affect cognition or induce any psychiatric problem at the doses generally use...
Autores principales: | Russo, Margherita, Rifici, Carmela, Sessa, Edoardo, D’Aleo, Giangaetano, Bramanti, Placido, Calabrò, Rocco Salvatore |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4407789/ https://www.ncbi.nlm.nih.gov/pubmed/25881038 http://dx.doi.org/10.1186/s40199-015-0109-6 |
Ejemplares similares
-
Sativex in the Management of Multiple Sclerosis-Related Spasticity: Role of the Corticospinal Modulation
por: Russo, Margherita, et al.
Publicado: (2015) -
Acute exacerbation of Hashimoto's thyroiditis in a patient treated with dimethyl fumarate for multiple sclerosis: A case report
por: Ciurleo, Rosella, et al.
Publicado: (2019) -
Impact of Depression, Fatigue, and Global Measure of Cortical Volume on Cognitive Impairment in Multiple Sclerosis
por: Nunnari, Domenica, et al.
Publicado: (2015) -
Twin pregnancy outcome following teriflunomide treatment in a relapsing-remitting multiple sclerosis patient: A case report
por: D’Aleo, Giangaetano, et al.
Publicado: (2020) -
The role of Sativex in robotic rehabilitation in individuals with multiple sclerosis: Rationale, study design, and methodology
por: Russo, Margherita, et al.
Publicado: (2017)